Breast Cancer Resources

home  »  cancer resources »  breast cancer

Breast Cancer Treatment Research and Sources of Information & Support

Kenneth S. Pope, Ph.D., ABPP

I gathered the resources on this page to help people with breast cancer and their loved ones to find information, support, and other resources. These resources are meant to complement and not replace any advice or information from a health care professional.

I created this site to be fully accessible for people with disabilities; please follow this link to change text size, color, or contrast; please follow this link for other accessibility functions for those with visual, mobility, and other disabilities.

There are 4 sections of resources:

1) 20 Books for learning about breast cancer, exploring treatment options, & coping effectively

2) 33 recent articles (i.e., published in 2016) on psychological aspects of breast cancer

3) 42 recent (i.e., published in 2016) research articles on breast cancer treatments

4) Links to 21 web sites providing information and support

PLEASE NOTE: This web site includes 8 other pages of related sets of resources:

20 BOOKS:

33 RECENT ARTICLES (I.E., PUBLISHED IN 2016) ON PSYCHOLOGICAL ASPECTS OF BREAST CANCER (E.G., COGNITIVE CHANGES, ANXIETY, DEPRESSION, POST-TRAUMATIC GROWTH, STRESS MANAGEMENT, QUALITY OF LIFE, PTSD, PSYCHOSOCIAL & CLINICAL INTERVENTIONS):

Adams, R. N., Mosher, C. E., Cohee, A. A., Stump, T. E., Monahan, P. O., Sledge, G. W., et al. (2016). Avoidant coping and self-efficacy mediate relationships between perceived social constraints and symptoms among long-term breast cancer survivors. Psycho-Oncology, published online in advance of print publication.

Alcorso, J., & Sherman, K. A. (2016). Factors associated with psychological distress in women with breast cancer-related lymphoedema. Psycho-Oncology, 25(7), 865-872. doi: 10.1002/pon.4021

Bouchard, L. C., Antoni, M. H., Blomberg, B. B., Stagl, J. M., Gudenkauf, L. M., Jutagir, D. R., et al. (2016). Postsurgical depressive symptoms and proinflammatory cytokine elevations in women undergoing primary treatment for breast cancer. Psychosomatic Medicine, 78(1), 26-37. doi: 10.1097/PSY.0000000000000261

Bourdon, M., Blanchin, M., Tessier, P., Campone, M., Quéreux, G., Dravet, F., et al. (2016). Changes in quality of life after a diagnosis of cancer: A 2-year study comparing breast cancer and melanoma patients. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation, 25(8), 1969-1979. doi: 10.1007/s11136-016-1244-3

Boyle, C. C., Stanton, A. L., Ganz, P. A., & Bower, J. E. (2016). Posttraumatic growth in breast cancer survivors: Does age matter? Psycho-Oncology, published online in advance of print publication.

Brandão, T., Schulz, M. S., & Matos, P. M. (2016). Psychological adjustment after breast cancer: A systematic review of longitudinal studies. Psycho-Oncology, published online in advance of print publication.

Brunault, P., Champagne, A. L., Huguet, G., Suzanne, I., Senon, J. L., Body, G., et al. (2016). Major depressive disorder, personality disorders, and coping strategies are independent risk factors for lower quality of life in non-metastatic breast cancer patients. Psycho-Oncology, 25(5), 513-520. doi: 10.1002/pon.3947

Carlson, L. E., Tamagawa, R., Stephen, J., Drysdale, E., Zhong, L., & Speca, M. (2016). Randomized-controlled trial of mindfulness-based cancer recovery versus supportive expressive group therapy among distressed breast cancer survivors (MINDSET): Long-term follow-up results. Psycho-Oncology, 25(7), 750-759. doi: 10.1002/pon.4150

Cohee, A. A., Stump, T., Adams, R. N., Johns, S. A., Von Ah, D., Zoppi, K., et al. (2016). Factors associated with depressive symptoms in young long-term breast cancer survivors. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation, 25(8), 1991-1997. doi: 10.1007/s11136-016-1241-6

Coroiu, A., Körner, A., Burke, S., Meterissian, S., & Sabiston, C. M. (2016). Stress and posttraumatic growth among survivors of breast cancer: A test of curvilinear effects. International Journal of Stress Management, 23(1), 84-97. doi: 10.1037/a0039247

Cvetkovi?, J., & Nenadovi?, M. (2016). Depression in breast cancer patients. Psychiatry Research, 240, 343-347. doi: 10.1016/j.psychres.2016.04.048

Damholdt, M. F., Mehlsen, M., O'Toole, M. S., Andreasen, R. K., Pedersen, A. D., & Zachariae, R. (2016). Web-based cognitive training for breast cancer survivors with cognitive complaints—a randomized controlled trial. Psycho-Oncology, published online in advance of print publication.

Gesselman, A. N., Bigatti, S. M., Garcia, J. R., Coe, K., Cella, D., & Champion, V. L. (2016). Spirituality, emotional distress, and post-traumatic growth in breast cancer survivors and their partners: An actor–partner interdependence modeling approach. Psycho-Oncology, published online in advance of print publication.

Gibbons, A., Groarke, A., Curtis, R., & Groarke, J. (2016). The effect of mode of detection of breast cancer on stress and distress. Psycho-Oncology, published online in advance of print publication.

Hopko, D. R., Clark, C. G., Cannity, K., & Bell, J. L. (2016). Pretreatment depression severity in breast cancer patients and its relation to treatment response to behavior therapy. Health Psychology, 35(1), 10-18. doi: 10.1037/hea0000252

Hsiao, F.-H., Jow, G.-M., Kuo, W.-H., Yang, P.-S., Lam, H.-B., Chang, K.-J., et al. (2016). The long-term effects of mindfulness added to family resilience-oriented couples support group on psychological well-being and cortisol responses in breast cancer survivors and their partners. Mindfulness, published online in advance of print publication.

Jung, M. S., Zhang, M., Askren, M. K., Berman, M. G., Peltier, S., Hayes, D. F., et al. (2016). Cognitive dysfunction and symptom burden in women treated for breast cancer: A prospective behavioral and fmri analysis. Brain Imaging and Behavior, published online in advance of print publication.

Kam, J. W. Y., Brenner, C. A., Handy, T. C., Boyd, L. A., Liu-Ambrose, T., Lim, H. J., et al. (2016). Sustained attention abnormalities in breast cancer survivors with cognitive deficits post chemotherapy: An electrophysiological study. Clinical Neurophysiology, 127(1), 369-378. doi: 10.1016/j.clinph.2015.03.007

Li, C., Zhou, C., & Li, R. (2016). Can exercise ameliorate aromatase inhibitor-induced cognitive decline in breast cancer patients? Molecular Neurobiology, 53(6), 4238-4246. doi: 10.1007/s12035-015-9341-9

Mackenzie, M. J., Zuniga, K. E., Raine, L. B., Awick, E. A., Hillman, C. H., Kramer, A. F., et al. (2016). Associations between physical fitness indices and working memory in breast cancer survivors and age-matched controls. Journal of Women's Health, 25(1), 99-108. doi: 10.1089/jwh.2015.5246

Manne, S. L., Siegel, S. D., Heckman, C. J., & Kashy, D. A. (2016). A randomized clinical trial of a supportive versus a skill-based couple-focused group intervention for breast cancer patients. Journal of Consulting and Clinical Psychology, 84(8), 668-681. doi: 10.1037/ccp0000110

Marroquín, B., Czamanski-Cohen, J., Weihs, K. L., & Stanton, A. L. (2016). Implicit loneliness, emotion regulation, and depressive symptoms in breast cancer survivors. Journal of Behavioral Medicine, published online in advance of print publication.

McLaughlin, B., Yang, J., Yoo, W., Shaw, B., Kim, S. Y., Shah, D., et al. (2016). The effects of expressing religious support online for breast cancer patients. Health Communication, 31(6), 762-771. doi: 10.1080/10410236.2015.1007550

Mens, M. G., Helgeson, V. S., Lembersky, B. C., Baum, A., & Scheier, M. F. (2016). Randomized psychosocial interventions for breast cancer: Impact on life purpose. Psycho-Oncology, 25(6), 618-625. doi: 10.1002/pon.3891

Moreno, P. I., Moskowitz, A. L., Ganz, P. A., & Bower, J. E. (2016). Positive affect and inflammatory activity in breast cancer survivors: Examining the role of affective arousal. Psychosomatic Medicine, 78(5), 532-541. doi: 10.1097/PSY.0000000000000300

Otto, A. K., Szczesny, E. C., Soriano, E. C., Laurenceau, J.-P., & Siegel, S. D. (2016). Effects of a Randomized Gratitude Intervention on Death-Related Fear of Recurrence in Breast Cancer Survivors. Health Psychology, published online in advance of print publication.

Paek, M.-S., Ip, E. H., Levine, B., & Avis, N. E. (2016). Longitudinal reciprocal relationships between quality of life and coping strategies among women with breast cancer. Annals of Behavioral Medicine, published online in advance of print publication.

Przezdziecki, A., Alcorso, J., & Sherman, K. A. (2016). My Changed Body: Background, development and acceptability of a self-compassion based writing activity for female survivors of breast cancer. Patient Education and Counseling, 99(5), 870-874. doi: 10.1016/j.pec.2015.12.011

Przezdziecki, A., & Sherman, K. A. (2016). Modifying affective and cognitive responses regarding body image difficulties in breast cancer survivors using a self-compassion-based writing intervention. Mindfulness, published online in advance of print publication.

Reed, R. G., Weihs, K. L., Sbarra, D. A., Breen, E. C., Irwin, M. R., & Butler, E. A. (2016). Emotional acceptance, inflammation, and sickness symptoms across the first two years following breast cancer diagnosis. Brain, Behavior, and Immunity, 56, 165-174. doi: 10.1016/j.bbi.2016.02.018

Saboonchi, F., Petersson, L. M., Alexanderson, K., Bränström, R., & Wennman-Larsen, A. (2016). Expecting the best and being prepared for the worst: Structure, profiles, and 2-year temporal stability of dispositional optimism in women with breast cancer. Psycho-Oncology, 25(8), 957-963. doi: 10.1002/pon.4045

Tabrizi, F. M., Radfar, M., & Taei, Z. (2016). Effects of supportive-expressive discussion groups on loneliness, hope and quality of life in breast cancer survivors: A randomized control trial. Psycho-Oncology, published online in advance of print publication.

Voigt, V., Neufeld, F., Kaste, J., Bühner, M., Sckopke, P., Wuerstlein, R., et al. (2016). Clinically assessed posttraumatic stress in patients with breast cancer during the first year after diagnosis in the prospective, longitudinal, controlled cognicares study. Psycho-Oncology, published online in advance of print publication.

42 RECENT (I.E., PUBLISHED IN 2016) RESEARCH ARTICLES ON TREATMENT APPROACHES FOR BREAST CANCER

  1. Broglio, K. R., Quintana, M., Foster, M., Olinger, M., McGlothlin, A., Berry, S. M., et al. (2016). Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes: A Meta-Analysis. JAMA Oncol, 2(6), 751-760. doi: 10.1001/jamaoncol.2015.6113

  2. Cheng, H., Clymer, J. W., Ferko, N. C., Patel, L., Soleas, I. M., Cameron, C. G., et al. (2016). A systematic review and meta-analysis of Harmonic technology compared with conventional techniques in mastectomy and breast-conserving surgery with lymphadenectomy for breast cancer. Breast Cancer (Dove Med Press), 8, 125-140. doi: 10.2147/BCTT.S110461

  3. Clavarezza, M., Puntoni, M., Gennari, A., Paleari, L., Provinciali, N., D'Amico, M., et al. (2016). Dual Block with Lapatinib and Trastuzumab Versus Single-Agent Trastuzumab Combined with Chemotherapy as Neoadjuvant Treatment of HER2-Positive Breast Cancer: A Meta-analysis of Randomized Trials. Clin Cancer Res. doi: 10.1158/1078-0432.CCR-15-1881

  4. Elgebaly, A., Menshawy, A., El Ashal, G., Osama, O., Ghanem, E., Omar, A., et al. (2016). Sunitinib alone or in combination with chemotherapy for the treatment of advanced breast cancer: A systematic review and meta-analysis. Breast Dis. doi: 10.3233/BD-160218

  5. Hu, X. Y., Huang, X. Y., Ma, J., Zuo, Y., Luo, N. B., Lai, S. L., et al. (2016). GSTT1 and GSTM1 polymorphisms predict treatment outcome for breast cancer: a systematic review and meta-analysis. Tumour Biol, 37(1), 151-162. doi: 10.1007/s13277-015-4401-3

  6. Mantarro, S., Rossi, M., Bonifazi, M., D'Amico, R., Blandizzi, C., La Vecchia, C., et al. (2016). Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer. Intern Emerg Med, 11(1), 123-140. doi: 10.1007/s11739-015-1362-x

  7. Munhoz, R. R., Pereira, A. A., Sasse, A. D., Hoff, P. M., Traina, T. A., Hudis, C. A., et al. (2016). Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis. JAMA Oncol, 2(1), 65-73. doi: 10.1001/jamaoncol.2015.3251

  8. Aseyev, O., Ribeiro, J. M., & Cardoso, F. (2016). Review on the clinical use of eribulin mesylate for the treatment of breast cancer. Expert Opin Pharmacother, 17(4), 589-600. doi: 10.1517/14656566.2016.1146683

  9. Balaji, K., Subramanian, B., Yadav, P., Anu Radha, C., & Ramasubramanian, V. (2016). Radiation therapy for breast cancer: Literature review. Med Dosim, 41(3), 253-257. doi: 10.1016/j.meddos.2016.06.005

  10. Beith, J., Burslem, K., Bell, R., Woodward, N., McCarthy, N., De Boer, R., et al. (2016). Hormone receptor positive, HER2 negative metastatic breast cancer: A systematic review of the current treatment landscape. Asia Pac J Clin Oncol, 12 Suppl 1, 3-18. doi: 10.1111/ajco.12491

  11. Elgebaly, A., Menshawy, A., El Ashal, G., Osama, O., Ghanem, E., Omar, A., et al. (2016). Sunitinib alone or in combination with chemotherapy for the treatment of advanced breast cancer: A systematic review and meta-analysis. Breast Dis. doi: 10.3233/BD-160218

  12. Gao, J., & Swain, S. M. (2016). Pertuzumab for the treatment of breast cancer: a safety review. Expert Opin Drug Saf, 15(6), 853-863. doi: 10.1517/14740338.2016.1167185

  13. George, B. P., & Abrahamse, H. (2016). A Review on Novel Breast Cancer Therapies: Photodynamic Therapy and Plant Derived Agent Induced Cell Death Mechanisms. Anticancer Agents Med Chem, 16(7), 793-801.

  14. Headon, H., Wazir, U., Kasem, A., & Mokbel, K. (2016). Surgical treatment of the primary tumour improves the overall survival in patients with metastatic breast cancer: A systematic review and meta-analysis. Mol Clin Oncol, 4(5), 863-867. doi: 10.3892/mco.2016.778

  15. Hu, X. Y., Huang, X. Y., Ma, J., Zuo, Y., Luo, N. B., Lai, S. L., et al. (2016). GSTT1 and GSTM1 polymorphisms predict treatment outcome for breast cancer: a systematic review and meta-analysis. Tumour Biol, 37(1), 151-162. doi: 10.1007/s13277-015-4401-3

  16. Johns, C., Seav, S. M., Dominick, S. A., Gorman, J. R., Li, H., Natarajan, L., et al. (2016). Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions. Breast Cancer Res Treat, 156(3), 415-426. doi: 10.1007/s10549-016-3765-4

  17. Kiba, T., Morii, N., Takahashi, H., Ozaki, S., Atsumi, M., Masumoto, F., et al. (2016). Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literature. Oncol Lett, 11(5), 3064-3070. doi: 10.3892/ol.2016.4334

  18. Li, J., Ren, J., & Sun, W. (2016). Systematic review of ixabepilone for treating metastatic breast cancer. Breast Cancer. doi: 10.1007/s12282-016-0717-0

  19. Li, Y., Zhu, X., Bensussan, A., Li, P., Moylan, E., Delaney, G., et al. (2016). Herbal Medicine for Hot Flushes Induced by Endocrine Therapy in Women with Breast Cancer: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med, 2016, 1327251. doi: 10.1155/2016/1327251

  20. Martinez, M. T., Perez-Fidalgo, J. A., Martin-Martorell, P., Cejalvo, J. M., Pons, V., Bermejo, B., et al. (2016). Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature. Crit Rev Oncol Hematol, 97, 96-106. doi: 10.1016/j.critrevonc.2015.08.011

  21. Martinez-Janez, N., Chacon, I., de Juan, A., Cruz-Merino, L., Del Barco, S., Fernandez, I., et al. (2016). Anti-HER2 Therapy Beyond Second-Line for HER2-Positive Metastatic Breast Cancer: A Short Review and Recommendations for Several Clinical Scenarios from a Spanish Expert Panel. Breast Care (Basel), 11(2), 133-138. doi: 10.1159/000443601

  22. Nicolini, A., Carpi, A., Ferrari, P., Biava, P. M., & Rossi, G. (2016). Immunotherapy and Hormone-therapy in Metastatic Breast Cancer: A Review and an Update. Curr Drug Targets, 17(10), 1127-1139.

  23. Niravath, P., Cakar, B., & Ellis, M. (2016). The Role of Genetic Testing in the Selection of Therapy for Breast Cancer: A Review. JAMA Oncol. doi: 10.1001/jamaoncol.2016.2719

  24. Papanikolaou, J. G. (2016). Oncoplastic breast-conserving surgery in breast cancer treatment Systematic review of the literature. Ann Ital Chir, 87, 199-208.

  25. Paracha, N., Thuresson, P. O., Moreno, S. G., & MacGilchrist, K. S. (2016). Health state utility values in locally advanced and metastatic breast cancer by treatment line: a systematic review. Expert Rev Pharmacoecon Outcomes Res, 1-11. doi: 10.1080/14737167.2016.1222907

  26. Peek, M. C., Ahmed, M., Napoli, A., Usiskin, S. I., Baker, R., & Douek, M. (2016). Minimal Invasive Ablative Techniques in the Treatment of Breast Cancer: a Systematic Review. Int J Hyperthermia, 1-43. doi: 10.1080/02656736.2016.1230232

  27. Rogan, S., Taeymans, J., Luginbuehl, H., Aebi, M., Mahnig, S., & Gebruers, N. (2016). Therapy modalities to reduce lymphoedema in female breast cancer patients: a systematic review and meta-analysis. Breast Cancer Res Treat, 159(1), 1-14. doi: 10.1007/s10549-016-3919-4

  28. Rossi, S., Schinzari, G., Basso, M., Strippoli, A., Dadduzio, V., D'Argento, E., et al. (2016). Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. Future Oncol, 12(10), 1299-1307. doi: 10.2217/fon-2015-0065

  29. Shah, R., Singh, J., Singh, D., Jaggi, A. S., & Singh, N. (2016). Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review. Eur J Med Chem, 114, 170-190. doi: 10.1016/j.ejmech.2016.02.054

  30. Sodergren, S. C., Copson, E., White, A., Efficace, F., Sprangers, M., Fitzsimmons, D., et al. (2016). Systematic Review of the Side Effects Associated With Anti-HER2-Targeted Therapies Used in the Treatment of Breast Cancer, on Behalf of the EORTC Quality of Life Group. Target Oncol, 11(3), 277-292. doi: 10.1007/s11523-015-0409-2

  31. Spring, L. M., Gupta, A., Reynolds, K. L., Gadd, M. A., Ellisen, L. W., Isakoff, S. J., et al. (2016). Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis. JAMA Oncol. doi: 10.1001/jamaoncol.2016.1897

  32. Squires, H., Stevenson, M., Simpson, E., Harvey, R., & Stevens, J. (2016). Trastuzumab Emtansine for Treating HER2-Positive, Unresectable, Locally Advanced or Metastatic Breast Cancer After Treatment with Trastuzumab and a Taxane: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 34(7), 673-680. doi: 10.1007/s40273-016-0386-z

  33. Sun, X., Zhang, X., Nian, J. Y., Guo, J., Yin, Y., Zhang, G. L., et al. (2016). Chinese Herbal Medicine as Adjunctive Therapy to Chemotherapy for Breast Cancer: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med, 2016, 3281968. doi: 10.1155/2016/3281968

  34. Swanick, C. W., & Smith, B. D. (2016). Indications for adjuvant radiation therapy in breast cancer: a review of the evidence and recommendations for clinical practice. Chin Clin Oncol, 5(3), 38. doi: 10.21037/cco.2016.03.15

  35. Verma, V., Vicini, F., Tendulkar, R. D., Khan, A. J., Wobb, J., Edwards-Bennett, S., et al. (2016). Role of Internal Mammary Node Radiation as a Part of Modern Breast Cancer Radiation Therapy: A Systematic Review. Int J Radiat Oncol Biol Phys, 95(2), 617-631. doi: 10.1016/j.ijrobp.2016.01.058

  36. Wang, Y., Yu, J., Cui, R., Lin, J., & Ding, X. (2016). Curcumin in Treating Breast Cancer: A Review. J Lab Autom. doi: 10.1177/2211068216655524

  37. Yang, G. S., Kim, H. J., Griffith, K. A., Zhu, S., Dorsey, S. G., & Renn, C. L. (2016). Interventions for the Treatment of Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors: A Systematic Review and Meta-analysis. Cancer Nurs. doi: 10.1097/NCC.0000000000000409

  38. Zafrakas, M., Papasozomenou, P., & Emmanouilides, C. (2016). Sorafenib in breast cancer treatment: A systematic review and overview of clinical trials. World J Clin Oncol, 7(4), 331-336. doi: 10.5306/wjco.v7.i4.331

  39. Zeichner, S. B., Terawaki, H., & Gogineni, K. (2016). A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer. Breast Cancer (Auckl), 10, 25-36. doi: 10.4137/BCBCR.S32783

  40. Zhang, T., Wang, R., Liu, Y., Huang, J., & Yang, Z. (2016). Efficacy and safety of doublet versus single agent as salvage treatment for metastatic breast cancer pretreated with anthracyclines and taxanes: a systematic review and meta-analysis. Curr Med Res Opin, 1-7. doi: 10.1080/03007995.2016.1219707

  41. Zhang, Y., Liang, J., Li, H., Cong, H., & Lin, Y. (2016). Risk of second primary breast cancer after radioactive iodine treatment in thyroid cancer: a systematic review and meta-analysis. Nucl Med Commun, 37(2), 110-115. doi: 10.1097/MNM.0000000000000419

  42. Zoghi, B., & Elledge, R. (2016). Endocrine Therapy for Leptomeningeal Metastases from ER-Positive Breast Cancer: Case Report and a Review of the Literature. Breast J, 22(2), 218-223. doi: 10.1111/tbj.12554

 

LINKS TO 21 WEB SITES THAT MAY BE USEFUL IN FINDING INFORMATION, GUIDANCE, AND SUPPORT:

 

[Back to Top]